- Home
- ULY vs TLPH Comparison
ULY vs TLPH Comparison
Compare ULY & TLPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ULY | TLPH |
|---|---|---|
| Founded | 2013 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.0M | 64.7M |
| IPO Year | N/A | 2011 |
Fundamental Metrics
Financial Performance| Metric | ULY | TLPH |
|---|---|---|
| Price | $2.17 | $1.07 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | ★ $11.50 | $6.00 |
| AVG Volume (30 Days) | 69.1K | ★ 365.3K |
| Earning Date | 11-12-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $127,932,000.00 | $28,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $18.95 | $14,267.20 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.74 | $0.38 |
| 52 Week High | $17.99 | $1.57 |
Technical Indicators
Market Signals| Indicator | ULY | TLPH |
|---|---|---|
| Relative Strength Index (RSI) | 43.80 | 37.24 |
| Support Level | $1.85 | $1.20 |
| Resistance Level | $2.26 | $1.25 |
| Average True Range (ATR) | 0.31 | 0.09 |
| MACD | 0.01 | -0.03 |
| Stochastic Oscillator | 23.91 | 10.14 |
Price Performance
Historical ComparisonAbout ULY Urgent.ly Inc.
Urgently Inc is a connected mobility assistance software platform, matching vehicle owners and operators with service professionals who deliver traditional roadside assistance, proactive maintenance and repair services. The traditional experience of a vehicle breakdown is often stressful and inconvenient, compounded by processes that lack transparency and to long wait times. Urgently offers an alternative to this traditional experience, leveraging its digitally native software platform to match supply and demand in its network and deliver exceptional mobility assistance experiences at scale.
About TLPH Talphera Inc.
Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. The Company's nafamostat product candidates include Niyad and LTX-608. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.